AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: An update on fatal and nonfatal systemic allergic reactions

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 2, 2014, Pages

  Epstein, Tolly G ^a,b   Liss, Gary M ^c   Murphy Berendts, Karen ^d   Bernstein, David I ^a,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Allergy Partners of Central Indiana   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Bernstein Clinical Research Center LLC   (United States)

Author keywords

Allergy shots; Anaphylaxis; Cluster immunotherapy; Pollen season; Subcutaneous allergen immunotherapy; Systemic reactions

Indexed keywords

ADULT; ALLERGIC REACTION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK REDUCTION; SKIN TEST; SUBCUTANEOUS IMMUNOTHERAPY; SYSTEMIC ALLERGIC REACTION; THERAPY EFFECT;

ALLERGY SHOTS; ANAPHYLAXIS; CLUSTER IMMUNOTHERAPY; POLLEN SEASON; SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY; SYSTEMIC REACTIONS;

DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; INJECTIONS, SUBCUTANEOUS; SKIN TESTS; TIME FACTORS;

EID: 84895419829     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.01.004     Document Type: Article

References (26)

1. Lockey R.F., Benedict L.M., Turkeltaub P.C., Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST). JAllergy Clin Immunol 1987, 79:660-677.
2. Matloff S.M., Bailit I.W., Parks P., Madden N., Greineder D.K. Systemic reactions to immunotherapy. Allergy Proc 1993, 14:347-350.
3. Moreno C., Cuesta-Herranz J., Fernandez-Tavora L., Alvarez-Cuesta E. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004, 34:527-531.
4. Ragusa V.F., Massolo A. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods. Eur Ann Allergy Clin Immunol 2004, 36:52-55.
5. Reid M.J., Lockey R.F., Turkeltaub P.C., Platts-Mills T.A. Survey of fatalities from skin testing and immunotherapy 1985-1989. JAllergy Clin Immunol 1993, 92:6-15.
6. Winther L., Arnved J., Malling H.J., Nolte H., Mosbech H. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study. Clin Exp Allergy 2006, 36:254-260.
7. Kannan J.A., Epstein T.G. Immunotherapy safety: what have we learned from surveillance surveys?. Curr Allergy Asthma Rep 2013, 13:381-388.
8. Bernstein D.I., Epstein T., Murphy-Berendts K., Liss G.M. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol 2010, 104:530-535.
9. Epstein T.G., Liss G.M., Murphy-Berendts K., Bernstein D.I. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2. Ann Allergy Asthma Immunol 2011, 107:426-431. e1.
10. Epstein T.G., Liss G.M., Murphy-Berendts K., Bernstein D.I. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, year 3: what practices modify the risk of systemic reactions?. Ann Allergy Asthma Immunol 2013, 110:274-278. e1.
11. Bernstein D.I., Wanner M., Borish L., Liss G.M. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. JAllergy Clin Immunol 2004, 113:1129-1136.
12. Joint Task Force of Practice Parameters Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003, 90(Suppl 1):1-40.
13. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(Suppl):S25-85.
14. Cox L., Nelson H., Lockey R., Calabria C., Chacko T., Finegold I., et al. Allergen immunotherapy: a practice parameter third update. JAllergy Clin Immunol 2011, 127(Suppl):S1-55.
15. Copenhaver C.C., Parker A., Patch S. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Ann Allergy Asthma Immunol 2011, 107:441-447.
16. Calabria C.W., Cox L. Accelerated immunotherapy schedules and premedication. Immunol Allergy Clin North Am 2011, 31:251-263. ix.
17. Cox L., Larenas-Linnemann D., Lockey R.F., Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. JAllergy Clin Immunol 2010, 125:569-574. 74.e1-74.e7.
18. Rueff F., Przybilla B., Bilo M.B., Muller U., Scheipl F., Aberer W., et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. JAllergy Clin Immunol 2009, 124:1047-1054.
19. Bhalla M.C., Gable B.D., Frey J.A., Reichenbach M.R., Wilber S.T. Predictors of epinephrine autoinjector needle length inadequacy. Am J Emerg Med 2013, 31:1671-1676.
20. Song T.T., Nelson M.R., Chang J.H., Engler R.J., Chowdhury B.A. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 2005, 94:539-542.
21. Rudders S.A., Geyer B.C., Banerji A., Phipatanakul W., Clark S., Camargo C.A. Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. JAllergy Clin Immunol 2012, 130:1216-1218.
22. Amin H.S., Liss G.M., Bernstein D.I. Evaluation of near-fatal reactions to allergen immunotherapy injections. JAllergy Clin Immunol 2006, 117:169-175.
23. Phillips J.F., Lockey R.F., Fox R.W., Ledford D.K., Glaum M.C. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy Asthma Proc 2011, 32:288-294.
24. Tinkelman D.G., Cole W.Q., Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. JAllergy Clin Immunol 1995, 95:8-14.
25. DaVeiga S.P., Liu X., Caruso K., Golubski S., Xu M., Lang D.M. Systemic reactions associated with subcutaneous allergen immunotherapy: timing and riskassessment. Ann Allergy Asthma Immunol 2011, 106:533-537. e2.
26. Liccardi G., D'Amato G., Canonica G.W., Salzillo A., Piccolo A., Passalacqua G. Systemic reactions from skin testing: literature review. JInvestig Allergol Clin Immunol 2006, 16:75-78.